J. Calnan & Associates, Inc. (JC&A), one of the leading construction management firms in the Northeast specializing in world-class pre-construction services and challenging construction projects, recently completed MassBioHub, MassBio’s new conference & business center.
Located at 700 Technology Square in Cambridge, the MassBioHub is a unique and flexible space to accommodate groups of 2-200 for all your business needs, from informal staff huddles to full-scale conferences and corporate events. From 1:1 interviews to large scale conferences, the MassBioHub is equipped with state-of-the-art audio-visual technology to help you produce a seamless and successful virtual event, or hold a COVID-19 compliant meeting safely and without added stress.
JC&A collaborated with TRIA, Inc., Alexandria Real Estate Equities, RW Sullivan and Fort Point Management on this exciting project that will allow scientists to focus on what they do best – improving patient lives.
The team integrated new AV, Security, Tel Data, and lighting control for the space and also installed a sound masking system to eliminate existing building noise. Designed to support networking opportunities, the space features multiple communal areas and an interconnecting black steel staircase with hand crafted Corian and pressure treated wood.
As companies are currently reconfiguring office and lab space to support social distancing, hosting a small meeting or event becomes near impossible due to space constraints. MassBioHub has the space and all the technology to ensure virtual events and meetings are engaging, professional and supports the evolving business needs of our Life Sciences community.
“It was an absolute pleasure to work with JC&A for the construction of MassBio’s new conference and business center. The team impressed us every step of the way with their responsiveness, attention to detail, and ability to stay focused on the client and project even through the COVID-19 pandemic. We could not be happier with the new space and look forward to a long partnership with JC&A,” said President and CEO of Mass Bio, Bob Coughlin.
“We are proud to be part of this important project for Mass Bio,” said Greg Lewis, project executive, Life Sciences at J. Calnan & Associates. “In the end, it’s all about improving patients’ lives, and this new headquarters will allow them to further advance their therapies.”
JC&A builds for the world’s top Life Sciences companies. Our specialized Life Sciences team has extensive experience working in challenging cGMP environments including occupied spaces, clean rooms, operational vivariums and labs. We also have worked for various user groups with strict security requirements and aggressive schedules. Some of these groups include Sanofi Genzyme, Biogen, Parexel International, Takeda, Acceleron and MassBio.
